Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Chromosomal Microarray: Application for Congenital Heart Diseases

  • Ko, Jung Min (Department of Pediatrics, Seoul National University Children's Hospital, Seoul National University College of Medicine)
  • Received : 2018.01.26
  • Accepted : 2018.01.29
  • Published : 2018.03.19
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010;86:749-64. https://doi.org/10.1016/j.ajhg.2010.04.006
  2. Manning M, Hudgins LProfessional Practice and Guidelines Committee. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 2010;12:742-5. https://doi.org/10.1097/GIM.0b013e3181f8baad
  3. Coulter ME, Miller DT, Harris DJ, et al. Chromosomal microarray testing influences medical management. Genet Med 2011;13:770-6. https://doi.org/10.1097/GIM.0b013e31821dd54a
  4. Battaglia A, Doccini V, Bernardini L, et al. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features. Eur J Paediatr Neurol 2013;17:589-99. https://doi.org/10.1016/j.ejpn.2013.04.010
  5. Bejjani BA, Saleki R, Ballif BC, et al. Use of targeted array-based CGH for the clinical diagnosis of chromosomal imbalance: is less more? Am J Med Genet A 2005;134:259-67.
  6. Barrett MT, Scheffer A, Ben-Dor A, et al. Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA. Proc Natl Acad Sci U S A 2004;101:17765-70. https://doi.org/10.1073/pnas.0407979101
  7. Stankiewicz P, Beaudet AL. Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation. Curr Opin Genet Dev 2007;17:182-92. https://doi.org/10.1016/j.gde.2007.04.009
  8. Keren B. The advantages of SNP arrays over CGH arrays. Mol Cytogenet 2014;7:I31. https://doi.org/10.1186/1755-8166-7-S1-I31
  9. Choi BG, Hwang SK, Kwon JE, Kim YH. Array comparative genomic hybridization as the first-line investigation for neonates with congenital heart disease: experience in a single tertiary center. Korean Circ J 2018;48:209-16. https://doi.org/10.4070/kcj.2017.0166

Cited by

  1. Chromosomal microarray detects genetic risks of neurodevelopmental disorders in newborns with congenital heart disease vol.31, pp.8, 2021, https://doi.org/10.1017/s1047951121000202